Shareholders meeting

August 26, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Bandra Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub: Proceedings of 48th Annual General Meeting held on Wednesday, August 26, 2026 pursuant to Regulation 30 and Voting Results along with Scrutinizer Report pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Dear Madam/Sirs, We wish to inform you that the 48th Annual General Meeting ("AGM") of Jubilant Pharmova Limited ("the Company") was held today, i.e., Wednesday, August 26, 2026, at 11:00 A.M. (IST) through Video Conferencing / Other Audio Visual Means ("VC/OAVM") and concluded at 12:13 P.M. (IST). All resolutions as mentioned in the Notice of the AGM were duly passed with the requisite majority. Pursuant to the provisions of Regulations 30 and 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the following documents: 1. Annexure-1: Summary of the proceedings of the 48th AGM of the Company. 2. Annexure-2: Details of voting results in respect of the 48th AGM held on Wednesday, August 26, 2026, through VC/OAVM, in compliance with Regulation 44(3). 3. Annexure-3: Consolidated Scrutinizer's Report dated August 26, 2026, on remote e-voting and e-voting conducted during the AGM, pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014. The above documents are being uploaded on the website of the Company at www.jubilantpharmova.com and National Securities Depositories Limited at www.evoting.nsdl.com. We request you to take the same on records. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Encl: As above National Securities Depository Limited Central Depository Services (India) Limited Trade World, A wing, 4th Floor, Kamala Marathon Futurex, A-Wing, 25th Floor, Mills Compound, Lower Parel, Mumbai- NM Joshi Marg, Lower Parel, Mumbai- 400013 400013 Annexure-1 Summary of Proceedings of the 48th Annual General Meeting of Jubilant Pharmova Limited The 48th Annual General Meeting ("AGM") of Jubilant Pharmova Limited ("the Company") was held today, i.e., Wednesday, August 26, 2026, at 11:00 a.m. (IST) through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM"), in accordance with the relevant circulars issued by the Ministry of Corporate Affairs ("MCA") and the Securities and Exchange Board of India ("SEBI"). The meeting commenced at 11:00 a.m. (IST) and concluded at 12:13 p.m. (IST), including the time allowed for e-voting during the AGM. A total of 86 members, representing 7,07,21,051 equity shares, attended the AGM through VC. The following Directors were present through VC at the AGM: S. No. Name of the Director Designation Place of attending AGM through VC 1. Mr. Shyam Sunder Bhartia Chairman New Delhi 2. Mr. Hari Shanker Bhartia Co-Chairman Noida 3. Mr. Priyavrat Bhartia Managing Director New Delhi 4. Mr. Arjun Shanker Bhartia Joint Managing Director New Delhi 5. Mr. Vivek Mehra Independent Director and Chairperson London of Audit Committee 6. Ms. Shivpriya Nanda Independent Director and Chairperson Gurugram of Sustainability and CSR Committee 7. Dr. Harsh Mahajan Independent Director New Delhi 8. Mr. Arun Seth Independent Director and Chairperson New Delhi of the Stakeholders’ Relationship Committee 9. Mr. Shirish G. Belapure Independent Director and Chairperson Ahmedabad of the Quality Committee 10. Mr. Sushil Kumar Roongta Independent Director and Chairperson Gurugram of the Nomination, Remuneration and Compensation Committee In attendance: S. No. Name of the attendee Designation Place of attending AGM through VC 1. Mr. Ashish Mukkirwar Chief Financial officer Noida 2. Mr. Naresh Kapoor Company Secretary Noida Invitees: S. No. Name of the invitee Designation Attended through VC from 1. Mr. Nitin Toshniwal Partner, M/s. Walker Chandiok & New Delhi Co., LLP, Chartered Accountants, Statutory Auditors. 2. Mr. Kapil Taneja Partner, M/s Sanjay Grover & New Delhi Associates, Company Secretaries, Secretarial Auditors. 3. Mr. Rupinder Singh Bhatia, Scrutinizer for the AGM. New Delhi Practicing Company Secretary (CP No. 2514) Mr. Shyam Sunder Bhartia, Chairperson, welcomed all the members attending the 48th AGM. As the requisite quorum was present, he called the meeting to order. The Chairperson introduced the Directors and Key Managerial Personnel participating in the meeting through Video Conferencing (VC). He also acknowledged the presence of Mr. Rupinder Singh Bhatia, Practising Company Secretary, as the Scrutinizer, along with representatives from the Statutory Auditors, Walker Chandiok & Co LLP, and the Secretarial Auditors, M/s Sanjay Grover & Associates, who attended the Annual General Meeting. The Chairperson further informed the Members that Mr. Arun Seth, Chairperson of the Stakeholders’ Relationship Committee, Mr. Sushil Kumar Roongta, Chairperson of the Nomination, Remuneration & Compensation Committee, and Mr. Vivek Mehra, Chairperson of the Audit Committee were present at the Meeting and available to address Members' queries pertaining to matters within the remit of their respective Committees. The Members were also informed that the Company had taken all necessary steps, in accordance with applicable legal provisions, to enable participation by the members in the meeting through VC and to enable Members to participate in the AGM through VC and to cast their votes electronically on the resolutions set out in the Notice convening the AGM. The Chairperson then delivered his address to the Members, highlighting, inter alia, the Company's financial and operational performance for the financial year 2025-26, the progress made towards Vision 2030, the launch of Line 3 at the Spokane facility, the transfer of the API business to Jubilant Biosys Limited, the economic outlook, initiatives relating to artificial intelligence and automation, the business outlook, performance for the first quarter of FY 2026-27, and the dividend recommendation. The Chairperson further informed that the Statutory Registers along with the Certificate issued by the Secretarial Auditors pursuant to the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and the other documents referred to in the AGM Notice were available for inspection electronically during the meeting. It was further informed that the Statutory Auditor's Report and Secretarial Auditor's Report for financial year 2025-26 does not contain any qualification, observation, adverse remark or disclaimer. With the consent of the members, the Notice convening the AGM for the financial year ended March 31, 2026, was taken as read. The Chairperson further informed the members that the Company had provided remote e-voting facility to the members holding shares on the Cut-off date i.e. Wednesday, August 19, 2026 (which started at 9:00 a.m. (IST) on Sunday, August 23, 2026 and ended at 5:00 p.m. (IST) on Tuesday, August 25, 2026) to cast their votes on all the resolutions set forth in the AGM Notice. Members who were participating in the meeting and had not casted their votes through remote e-voting, were provided an opportunity to cast their votes through e-voting at the meeting. The following items as stated in the notice of the 48th AGM were considered at the meeting: Item No. Particulars Type of Resolutions ORDINARY BUSINESS 1. To receive, consider and adopt: Ordinary Resolution (a) the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and the Auditors thereon; (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026 together with the Report of the Auditors thereon. [Showing first 8,000 characters — download PDF for full document]